about
Vaxjo: a web-based vaccine adjuvant database and its application for analysis of vaccine adjuvants and their uses in vaccine developmentThe germinal center antibody response in health and diseaseAdjuvants: Classification, Modus Operandi, and LicensingRecent advances of biomaterials in biotherapyPathogen-Associated Molecular Patterns Induced Crosstalk between Dendritic Cells, T Helper Cells, and Natural Killer Helper Cells Can Improve Dendritic Cell VaccinationRoles and relevance of mast cells in infection and vaccinationChoice and Design of Adjuvants for Parenteral and Mucosal VaccinesVaccine Adjuvants: from 1920 to 2015 and BeyondSystems biology from virus to humansAdvances in structure-based vaccine designBeyond empiricism: informing vaccine development through innate immunity researchProphylactic vaccinations in chronic kidney disease: Current statusContribution of Toll-like receptor signaling to germinal center antibody responsesHeat shock proteins: stimulators of innate and acquired immunitySystems biology applied to vaccine and immunotherapy developmentApproaches to vaccines against Orientia tsutsugamushiPolyionic vaccine adjuvants: another look at aluminum salts and polyelectrolytesRecognition of Extracellular Bacteria by NLRs and Its Role in the Development of Adaptive ImmunitySafety assessment of adjuvanted vaccines: Methodological considerationsRationale, progress and development of vaccines utilizing STING-activating cyclic dinucleotide adjuvantsThe Endoplasmic Reticulum Chaperone GRP170: From Immunobiology to Cancer TherapeuticsMixed adjuvant formulations reveal a new combination that elicit antibody response comparable to Freund's adjuvantsTRIF is a critical negative regulator of TLR agonist mediated activation of dendritic cells in vivoStructure and Immunogenicity of a Peptide Vaccine, Including the Complete HIV-1 gp41 2F5 EpitopeProtection of young children from influenza through universal vaccination.Biodegradable Polymeric Nanoparticles-Based Vaccine Adjuvants for Lymph Nodes TargetingLocal innate immune responses in the vaccine adjuvant-injected muscleRecent advances of vaccine adjuvants for infectious diseasesTrypanosoma cruzi adjuvants potentiate T cell-mediated immunity induced by a NY-ESO-1 based antitumor vaccineNear-infrared laser adjuvant for influenza vaccineEnhancing the work of the Department of Health and Human Services national vaccine program in global immunization: recommendations of the National Vaccine Advisory Committee: approved by the National Vaccine Advisory Committee on September 12, 2013The adjuvanticity of an O. volvulus-derived rOv-ASP-1 protein in mice using sequential vaccinations and in non-human primatesAge-dependent maturation of Toll-like receptor-mediated cytokine responses in Gambian infantsImmunogenicity and reactogenicity of 2009 influenza A (H1N1) inactivated monovalent non-adjuvanted vaccine in elderly and immunocompromised patientsBacterial-Derived Polymer Poly-γ-Glutamic Acid (γ-PGA)-Based Micro/Nanoparticles as a Delivery System for Antimicrobials and Other Biomedical ApplicationsA Novel Agonist of the TRIF Pathway Induces a Cellular State Refractory to Replication of Zika, Chikungunya, and Dengue Viruses.Preclinical evaluation of Vaxfectin-adjuvanted Vero cell-derived seasonal split and pandemic whole virus influenza vaccinesNew vaccines against influenza virus.Dual effect of Thymosin α 1 on human monocyte-derived dendritic cell in vitro stimulated with viral and bacterial toll-like receptor agonists.Single-Dose CpG Immunization Protects Against a Heterosubtypic Challenge and Generates Antigen-Specific Memory T Cells.
P2860
Q21284959-DF66B692-03F2-44EA-84CB-C4DEE690AC40Q26745929-12308C91-8B6C-43DE-98BB-F7EFD2B1429AQ26747586-04E3E861-BE16-4732-9EC8-2038BD083E1DQ26752054-FD3A8A0E-5C20-4845-85B8-99A65580A2BCQ26765345-3D53D463-526C-42CB-A9B6-C9A357AA1AE8Q26777264-4CBED651-CFAE-4E78-92EF-21BA28A5EE4AQ26783488-DAAAA38F-2D1F-44DF-B20B-B6A7EE8EAB00Q26783879-7B6BB91D-624F-4364-919C-3CA8ED95D6F0Q26798272-021B7710-D0AB-40AB-B8B5-0E1C734EC296Q26824545-119C44FB-D123-4EB3-9658-2C7B1036F647Q26824573-816EFE19-B087-49A1-B0F0-59DB5574C1DDQ26827388-DD6A8FF9-6E17-4A7E-A27C-BD317BCE9FCBQ26829061-48EB00A6-4506-4E50-B793-FC972557482AQ26829100-D28720A3-461B-47FA-8DB5-6FAF3CB6117BQ26830374-D0D7FAEC-D729-42F0-A021-B981D5A969FBQ26849239-439ED3F8-2EB4-429D-99B5-6C763BB7FA13Q26852816-91D733AD-20F9-46F0-95EA-7516DEC3296AQ27008302-7EF558AB-8E74-4070-8BD3-4F9B9546550CQ27013956-5404E228-D70A-43B6-9CA0-DF961C3D6404Q27025822-56A71FAD-50C7-4FC7-A994-7FAAE3B9D5BBQ27026256-F4A818D1-3EE7-4618-BAE0-979E5B7C1BC8Q27304735-ACD2A6DB-2B5C-40C9-B7F8-685CE6F7D45DQ27332276-0042277A-7A48-42CA-B73E-A2CF4AC29806Q27681352-7A82BB54-5ECB-4852-9281-E91B4CB1B6EEQ27693242-F94E66C8-65C1-4E9F-85D1-D542DF4005EAQ28072997-6AE469FD-7F90-4D46-93AA-9A8E3BE876D0Q28079872-3DE97333-BE4B-48A7-BEB7-43873BF63006Q28083679-8E72F9AC-74C9-40F8-B429-3F931E3F0E9AQ28483146-329949A4-4790-432D-9267-9BB62D46DCB0Q28536886-276B5043-8FB1-47DB-9050-B4BA2D1B5410Q28654939-4E3B6941-29CE-4F90-BC8B-EB5A0191DAD0Q28729899-B9851E85-7BBD-4844-8AAD-AC4A02FB3A48Q28741059-6B2E2CCA-F350-4F84-9C8F-65CA0DC112B4Q28743021-1D5C9213-8FE8-4D3A-B054-63547F9CBD43Q29248031-4B12825D-5AFB-4E2B-85F8-4871709EC4FBQ30145658-00AB88E9-8AF8-4E04-AD6D-E95F56A6CB29Q30352121-633A46A1-772D-469A-A0DD-21C5B4B2F185Q30357932-0E80B38F-6D0A-42FB-8DF4-497530B172CAQ30375943-E5E7DEAD-3ABA-47EE-97C0-93026D6DCD12Q30376518-DCE018EB-AA4C-4410-8CF2-D1CA716C9113
P2860
description
2010 nî lūn-bûn
@nan
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
2010年论文
@zh
2010年论文
@zh-cn
name
Vaccine adjuvants: putting innate immunity to work.
@ast
Vaccine adjuvants: putting innate immunity to work.
@en
type
label
Vaccine adjuvants: putting innate immunity to work.
@ast
Vaccine adjuvants: putting innate immunity to work.
@en
prefLabel
Vaccine adjuvants: putting innate immunity to work.
@ast
Vaccine adjuvants: putting innate immunity to work.
@en
P2093
P2860
P1433
P1476
Vaccine adjuvants: putting innate immunity to work.
@en
P2093
Robert A Seder
Robert L Coffman
P2860
P304
P356
10.1016/J.IMMUNI.2010.10.002
P407
P577
2010-10-01T00:00:00Z